Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities

Clinical and Experimental Rheumatology

Volumn 26, Issue 6, 2008, Pages 986-991

  Peris, Pilar ^a   Ruiz Esquide, Virginia ^a   Monegal, Ana ^a   Alvarez, Luisa ^a   de Osaba, Ma Jesús Martínez ^a   Martínez Ferrer, Ángeles ^a   Reyes, Raquel ^a   Guañabens, Nuria ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bone markers; Bone turnover; Low bone mass; Premenopausal osteoporosis; Primary osteoporosis

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; HYDROXYPROLINE; PARATHYROID HORMONE; PROCOLLAGEN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ARTICLE; BONE DENSITY; BONE MASS; BONE REMODELING; CALCIUM EXCRETION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FEMUR; FRAGILITY FRACTURE; HUMAN; HYDROXYPROLINE URINE LEVEL; HYPERCALCIURIA; IDIOPATHIC OSTEOPOROSIS; LABORATORY TEST; LUMBAR SPINE; OSSIFICATION; OSTEOLYSIS; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SPINE RADIOGRAPHY;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; FEMALE; FRACTURES, BONE; HUMANS; HYPERCALCIURIA; MIDDLE AGED; OSTEOPOROSIS; PREMENOPAUSE; RISK FACTORS;

EID: 59149094629     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. KANIS JA, DELMAS P, BURCKHARDT P, COOPER C, TORGERSON D: Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997; 7: 390-406.
2. DÍAZ CURIEL M, GARCÍA JJ, CARRASCO JL et al.: Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc) 2001; 116: 86-8.
3. PERIS P, GUAÑABENS N, MARTÍNEZ DE OSABA MJ et al.: Clinical Characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002; 32: 64-70.
4. MOREIRA KULAK CA, SCHUSSCHEIM DH, MCMAHON DJ et al.: Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract 2000; 6: 296-304.
5. KAUFMAN JM, JOHNELL O, ABADIE E et al.: Background for studies on the treatment of male osteoporosis: State of the art. Ann Rheum Dis 2000; 59: 765-72.
6. PERIS P, MARTÍNEZ MA, MONEGAL A et al.: Etiology and clinical characteristics of male osteoporosis: Have they changed in the past few years? J Bone Miner Res 2006; 21 (Suppl. 1): S177.
7. PIETSCHMANN P, KUDLACEK S, GRISAR J et al.: Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 2001; 31; 444-51.
8. GHAZALI A, FUENTES V, DESAINT C et al.: Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82: 32-8.
9. JOHANSSON AG, ERIKSEN EF, LINDH E et al.: Reduced serum levels of growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodelling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 1997; 82: 2795-88.
10. KHOSLA S, LUFKIN EG, HODGSON SF, FRITZ-PATRICK LA, MELTON LJ 3RD: Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994; 15: 551-5.
11. CALÒ L, CASTRIGNANO R, DAVIS PA et al.: Role of insulin-like growth factor-I in primary osteoporosis: A correlative study. J Endocrinol Invest 2000; 23: 223-7.
12. CIRIA-RECASENS M, PEREZ-EDO L, BLANCH-RUBIO J et al.: Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis. Bone 2005; 36: 926-30.
13. DONOVAN MA, DEMPSTER D, ZHOU H, MCMAHON DJ, FLEISHER J, SHANE E: Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2005; 90: 3331-6.
14. RUBIN MR, SCHUSSHEIM DH, KULAK CAM et al.: Idiopathic osteoporosis in premenopausal women. Osteoporos Int 2005; 16: 526-533.
15. LEIB ES, LEWIECKI EM, BINKLEY N, HAMDY RC: Official positions of the International Society for Clinical Densitometry. J Clin Densitom 2004; 7: 1-5.
16. PERIS P, GUAÑABENS N, MONEGAL A et al.: Aetiology and presenting symptoms in male osteoporosis. Br J Rheumatol 1995; 34: 936-41.
17. GOURLAY ML, BROWN SA: Clinical considerations in premenopausal osteoporosis. Arch Intern Med 2004; 164: 603-14.
18. COHEN-SOLAL ME, BAUDOIN C, OMOURI M, KUNTZ D, DE VERNEJOUL MC: Bone mass in middle-aged osteoporotic men and their relatives: Familial effect. J Bone Miner Res 1998; 13: 1909-14.
19. ERBAS B, RISTEVSKI S, POON C, YEUNG S, EBELING PR: Decreased spinal and femoral neck volumetric bone mineral density (BMD) in men with primary osteoporosis and their first-degree male relatives: Familial effect on BMD in men. Clin Endocrinol 2007; 66: 78-84.
20. DANIELSON ME, CAULAY JA, BAKER CE et al.: Familiar resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: The BMD in mothers and daughters study. J Bone Miner Res 1999; 14: 102-10.
21. VAN POTTELBERGH I, GOEMAERE S, ZMIERCZAK H, DE BACQUER D, KAUFMAN JM: Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: Evidence from a three-generation family study. J Bone Miner Res 2003; 18: 303-11.
22. MEIN AL, BRIFFA NK, DHALIWAL SS, PRINCE R: Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 2004; 19: 1092-8.
23. LLOYD T, ANDON M, ROLLINGS N et al.: Calcium supplementation and bone mineral density in adolescent girls. JAMA 1993; 270: 841-4.
24. BARAN D, SORENSEN A, GRIMES J et al.: Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: A three-year prospective study. J Clin Endocrinol Metab 1990; 70: 264-70.
25. BLUMM M, HARRIS SS, MUST A, PHILLIPS SM, RAND WM, DAWSON-HUGHES B: Weight and body mass index at menarche are associated with premenopausal bone mass. Osteoporos Int 2001; 12: 588-94.
26. HAWKER GA, JAMAL SA, RIDOUT R, CHASE C: A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int 2002; 13: 400-6.
27. HELLER HJ, ZERWEKH JE, GOTTSCHALK FA, PAK CYC: Reduced bone formation and relatively increased bone resorption in absortive hypercalciuria. Kidney Int 2007; 71: 808-15.
28. GARCÍA-NIETO V, NAVARRO JF, MONGE M, GARCÍA RODRÍGUEZ VE: Bone mineral density in girls and their mothers with idiopathic hypercalciuria. Nephon Clin Pract 2003; 94: c89-93.
29. CAUDARELLA R, VESCINI F, BUFFA A et al.: Bone mass loss in calcium stone disease: Focus on hypercalciuria and metabolic factors. J Nephrol 2003; 16: 260-6.
30. JP BILEZIKIAN, ES KURLAND, CJ ROSEN: Idiopathic osteoporosis in men. In ES ORWOLL (Ed.) Osteoporosis in men. The effects of gender on skeletal health. Academic Press, San Diego 1999, 395-416.
31. PACIFICI R: Idiopathic hyercalciuria and osteoporosis-Distinct clinical manifestations of increased cytokine-induced bone resorption? J Clin Endocrinol Metab 1997; 82: 29-31.
32. PERNOW Y, GRANBERG B, SÄÄF M, WEIDENHIELM L: Osteoblast dysfunction in male idiopathic osteoporosis. Calcif Tissue Int 2006; 78: 90-7.
33. LORMEAU C, SOUDAN B, D' HERBOMEZ M, PIGNY P, DUQUESNOY B, CORTET B: Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 2004; 933-9.
34. FLEDELIUS C, JOHNSEN AH, CLOOS PAC, BONDE M, QVIST P: Characterization of urinary degradation products derived from type I collagen. J Biol Chem 1997; 272; 9755-63.
35. PERIS P, ALVAREZ L, MONEGAL A et al.: Effects of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: Evolution after antiresoptive therapy. J Bone Miner Metab 2002; 20: 117-21.
36. DE LA PIEDRA C, CALERO JA, TRABA ML, ASENSIO MD, ARGENTE J, MUÑOS MT: Urinary α and β C-telopepetides of collagen I: Clinical implications in bone remodeling in patients with anorexia nervosa. Osteoporos Int 1999; 10: 480-6.
37. ALEXANDERSEN P, PERIS P, GUAÑABENS N et al.: Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone. J Bone Miner Res 2005; 20: 588-95.
38. HOSHINO H, TAKAHASHI M, KUSHIDA K, OHISHI T, INOUE T: The relationships between the degree of β-isomerization of type I collagen degradation products in urine and aging, menopause and osteoporosis with fractures. Osteoporos Int 1999; 9: 405-9.
39. DE PAPP AE, BONE HG, CAULFIELD MP, KAGAN R, BUINEWICZ A, CHEN E: A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone 2007; 40: 1222-30.